Literature DB >> 34035361

White matter hyperintensity in different migraine subtypes.

L A Dobrynina1, A D Suslina2, M V Gubanova3, A V Belopasova1, A N Sergeeva2, S Evers4, E V Gnedovskaya1, M V Krotenkova2.   

Abstract

The diagnostic value of white matter hyperintensities (WMH) in different types of migraineare unknown. To evaluate the WMH pattern of different subtypes in migraine patients with no vascular risk factors. 92 migraine patients (73 females, mean age 34.6 ± 8.9; 61 episodic migraine, 31 chronic migraine, 36 migraine with aura, 56 migraine without aura) without vascular risk factors underwent brain MRI (3 T). We also included a matched healthy control group with no migraine (n = 24). The prevalence of WMH in different types of migraine was similar and ranged from 38.7 to 44.4%; the control group showed no WMH at all. Lesions were located within frontal, parietal and temporal lobes (in order of decreasing incidence) in juxtacortical and/or deep white matter. WMH appeared as round or slightly elongated foci with a median size of 2.5 mm [1.5; 3]. Total number, size and prevalence of WMH by lobes and white matter regions were similar between groups, and no interaction with age or sex was found. The number of lesions within the frontal lobe juxtacortical white matter correlated with the age of patients (r = 0.331, p = 0.001) and the duration since migraine onset (r = 0.264, p = 0.012). Patients with different migraine subtypes and without vascular risk factors are characterized by a similar pattern of WMH in the absence of subclinical infarctions or microbleedings. Therefore, WMH have no relevant prognostic value regarding the course of migraine and vascular complications. WMH pattern may be used to differentiate migraine as a primary disorder and other disorders with migraine-like headache and WMH.

Entities:  

Year:  2021        PMID: 34035361     DOI: 10.1038/s41598-021-90341-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  10 in total

1.  High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.

Authors:  Gregory A Roth; Stephan D Fihn; Ali H Mokdad; Wichai Aekplakorn; Toshihiko Hasegawa; Stephen S Lim
Journal:  Bull World Health Organ       Date:  2010-09-03       Impact factor: 9.408

2.  Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine.

Authors:  Flavia M Gonçalves; Alisson Martins-Oliveira; Jose G Speciali; Tatiane C Izidoro-Toledo; Marcelo R Luizon; Fabiola Dach; Jose E Tanus-Santos
Journal:  DNA Cell Biol       Date:  2010-07       Impact factor: 3.311

Review 3.  Migraine and white matter hyperintensities.

Authors:  Alyx Porter; Jonathan P Gladstone; David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2005-08

4.  Characteristic analysis of white matter lesions in migraine patients with MRI.

Authors:  F Hu; Z-W Qian
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016       Impact factor: 3.507

5.  Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.

Authors:  David W Dodick; Stewart J Tepper; Richard B Lipton; Dawn C Buse; Walter F Stewart; Martha Bayliss; Pooja Desai; Sandhya Sapra; Karla Anderson; Erin McInerney-Prichard
Journal:  Headache       Date:  2018-10       Impact factor: 5.887

6.  Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients.

Authors:  Anita Trauninger; Eszter Leél-Ossy; David Olayinka Kamson; László Pótó; Mihály Aradi; Ferenc Kövér; Marianna Imre; Hedvig Komáromy; Szilvia Erdélyi-Botor; Agnes Patzkó; Zoltán Pfund
Journal:  J Headache Pain       Date:  2011-02-18       Impact factor: 7.277

Review 7.  CNS Vasculitis: an Approach to Differential Diagnosis and Management.

Authors:  Kevin Byram; Rula A Hajj-Ali; Leonard Calabrese
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.686

8.  Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging.

Authors:  Mohamed Negm; Ahmed Mohamed Housseini; Mohamed Abdelfatah; Alshimaa Asran
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-09-10

Review 9.  Cognitive dysfunction and migraine.

Authors:  Doga Vuralli; Cenk Ayata; Hayrunnisa Bolay
Journal:  J Headache Pain       Date:  2018-11-15       Impact factor: 7.277

10.  Association of white matter hyperintensities with migraine features and prognosis.

Authors:  Hui Xie; Qiang Zhang; Kang Huo; Rui Liu; Zhi-Jie Jian; Yi-Tong Bian; Guo-Liang Li; Dan Zhu; Li-Hui Zhang; Jian Yang; Guo-Gang Luo
Journal:  BMC Neurol       Date:  2018-07-02       Impact factor: 2.474

  10 in total
  2 in total

1.  Risk factors of white matter hyperintensities in migraine patients.

Authors:  Jasem Yousef Al-Hashel; Raed Alroughani; Khaled Gad; Lamiaa Al-Sarraf; Samar Farouk Ahmed
Journal:  BMC Neurol       Date:  2022-04-29       Impact factor: 2.903

2.  Evaluating the relationship between right-to-left shunt and white matter hyperintensities in migraine patients: A systematic review and meta-analysis.

Authors:  Joshua Y P Yeo; Claire X Y Goh; Ying Kiat Tan; Bryan T S Sim; Beverly L X Chan; Nicholas L Syn; Yinghao Lim; Amanda C Y Chan; Vijay K Sharma; Jonathan J Y Ong; Leonard L L Yeo; Ching-Hui Sia; Benjamin Y Q Tan
Journal:  Front Neurol       Date:  2022-08-18       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.